Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults

Launched by UNIVERSITY OF MINNESOTA · Jan 16, 2024

Keywords

ClinConnect Summary

The Project SHINE trial is studying ways to help African American adults who struggle with obesity and don’t get enough sleep. The goal is to understand how sleep, physical activity, and lifestyle choices affect health in this group and to test a program designed to improve sleep and encourage more physical activity. The study is divided into two phases. In the first phase, researchers will talk with participants to learn about their sleep habits and get feedback on a planned sleep intervention. In the second phase, a clinical trial will take place to see how effective this sleep intervention is in helping participants sleep longer and be more active.

To be eligible for this study, participants should be African American adults aged 21 to 75, have a body mass index (BMI) of 25 or higher (which indicates being overweight), and report getting an average of 6 hours or less of sleep each night. Participants in both phases will have the opportunity to share their experiences and receive a program aimed at improving their sleep and activity levels. It’s important to note that those with certain health conditions or who are pregnant or have a very young child at home are not eligible to participate. The information gathered from the first phase will help shape the second phase of the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Phase 1:
• • Not meeting Physical Activity Guidelines
• • age range: 21 to 75 years
• • body mass index: ≥25.0 kg/m2
• • average self-reported habitual sleep duration of ≤6 hours
• • self-identify as Black or African American
• Phase 2:
• • Not meeting Physical Activity Guidelines
• • age range: 21 to 75 years
• • body mass index: ≥25.0 kg/m2
• • average self-reported habitual sleep duration of ≤6 hours
• • self-identify as Black or African American
• Exclusion Criteria:
• Phase 1:
• • Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophageal disorder)
• • pregnant or less than 4 months postpartum
• • infant living in household less than 1 year old
• Phase 2:
• • Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophageal disorder)
• • pregnant or less than 4 months postpartum
• • infant living in household less than 1 year old